Osteosarcoma growth suppression by riluzole delivery via iron oxide nanocage in nude mice

Osteosarcomas are the most commonly occurring malignant bone cancer in young individuals. The survival rate of patients with metastatic osteosarcoma is low and has been stagnant for over two decades. We previously demonstrated that the glutamate release inhibitor, riluzole inhibits osteosarcoma cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghubir, Marian, Rahman, Chowdhury Nowshin, Fang, Justin, Matsui, Hiroshi, Mahajan, Shahana Sultana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921406/
https://www.ncbi.nlm.nih.gov/pubmed/31789402
http://dx.doi.org/10.3892/or.2019.7420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921406/
https://www.ncbi.nlm.nih.gov/pubmed/31789402
http://dx.doi.org/10.3892/or.2019.7420

Ejemplares similares